NKP608

CAT: 0804-HY-18006-01Size: 5 mgDry Ice: NoHazardous: No

1 / 1

CAT#:0804-HY-18006-01Size:5 mg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

NKP608 is a non-peptidic derivative of 4-aminopiperidine which acts as a selective, specific and potent antagonist at the neurokinin-1 (NK-1) receptor both in vitro (IC50=2.6 nM) and in vivo. IC50 value: 2.6 nM Target: NK-1 receptor In vitro, the binding of NKP608 to bovine retina was characterized by an IC50 of 2.6+/-0.4 nM, whereas the compound's affinity to other receptor binding sites, including NK-2 and NK-3, was much lower. Species differences in IC (50) values with NKP608 were less pronounced than with previously described NK-1 receptor antagonists, being 13+/-2 and 27+/-2 nM in gerbil midbrain and rat striatum, respectively. In vivo, using the hind foot thumping model in gerbils, NKP608 exhibited a potent NK-1 antagonistic activity following oral administration (ID (50) =0.23 mg/kg; 2 h pretreatment), supporting a central activity of NKP608. NKP608 may prove a useful anxiolytic compound.

CAS Number

177707-12-9

UNSPSC

12352005

Target

Neurokinin Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease; Endocrinology

Assay Protocol

https://www.medchemexpress.com/NKP608.html

Purity

99.88

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

O=C(C1=CC=NC2=CC=CC=C12)N[C@@H]3C[C@@H](CC4=CC=C(Cl)C=C4)N(C(C5=CC(C(F)(F)F)=CC(C(F)(F)F)=C5)=O)CC3

Molecular Formula

C31H24ClF6N3O2

Molecular Weight

619.98

References & Citations

[1]El-Hashim AZ, Wyss D, Lewis C. Effect of a novel NK1 receptor selective antagonist (NKP608) on citric acid induced cough and airway obstruction. Pulm Pharmacol Ther. 2004;17 (1) :11-8.|[2]Vendruscolo LF, Takahashi RN, Brüske GR, Ramos A. Evaluation of the anxiolytic-like effect of NKP608, a NK1-receptor antagonist, in two rat strains that differ in anxiety-related behaviors. Psychopharmacology (Berl) . 2003 Nov;170 (3) :287-93.|[3]Rupniak NM, Carlson EJ, Shepheard S, et al. Comparison of the functional blockade of rat substance P (NK1) receptors by GR205171, RP67580, SR140333 and NKP-608. Neuropharmacology. 2003 Aug;45 (2) :231-41.|[4]Gentsch C, Cutler M, Vassout A, et al. Anxiolytic effect of NKP608, a NK1-receptor antagonist, in the social investigation test in gerbils. Behav Brain Res. 2002 Jul 18;133 (2) :363-8.|[5]Vassout A, Veenstra S, Hauser K, et al. NKP608: a selective NK-1 receptor antagonist with anxiolytic-like effects in the social interaction and social exploration test in rats. Regul Pept. 2000 Dec 22;96 (1-2) :7-16.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

Phase 2

Related Products

Catalog	Name
HY-P84990	NKp30 Antibody (YA4682, Mouse)
HY-P83817-01	NKp30 Antibody (YA3514, Mouse)
HY-P81726-01	NKp30 Antibody (YA1471, Rabbit)
HY-P85019	NKp80 Antibody (YA4711, Mouse)
HY-P72506-01	NKp30/NCR3, Human (HEK293, His)
HY-P72501-01	NKp80/KLRF1, Human (HEK293, His)
HY-P77453-01	NKp80/KLRF1, Cynomolgus (HEK293, Fc)
HY-P77106-01	NKp30/NCR3, Rat (HEK293, His)
HY-P77811-01	NKp30/NCR3, Human (HEK293, Fc)
HY-P77812	NKp30/NCR3, Human (HEK293, His-Avi)

Alternative Products

Catalog	Name
MBS5764344	NKP608
A15187-10	NKP608 10mg
A15187-50	NKP608 50mg
A15187-2	NKP608 2mg
A15187-100	NKP608 100mg
A15187-5	NKP608 5mg
A15187-25	NKP608 25mg

NKP608

Related Products

Alternative Products

Popular Products